4 Drugs Facing Key Patent Expirations and Potential Generic Entry From September 2021–November 2021
A challenge in anticipating generic entry is elucidating which patents and regulatory protections constrain generic entry. Yali Friedman at DrugPatentWatch presents a...
Continue Reading →
